Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa
Recruiting
Observational Study
Chronic Kidney Diseases
Type 2 Diabetes Mellitus
Arterial Hypertension
Obesity
Cardiovascular Diseases
HIV Infections
Anemia
Underweight
Infections
Albuminuria
Dyslipidemias
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 99
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,200 (estimated)
- Sponsor
- Swiss Tropical & Public Health Institute · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Chronic kidney disease (CKD) is associated with increased cardiovascular morbidity and mortality. The prevalence of CKD is increasing worldwide and is assumed to also dramatically increase in Sub-Saharan Africa (SSA). Key shortcomings of available data on CKD in SSA are as follows: (i) Available data are based on single measurements and, therefore, cannot distinguish between harmless transient det…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
all adult patients (≥18 years) attending the outpatients department of the Bagamoyo district hospital (BDH) or the associated Fukayosi and Yombo dispensary
Exclusion Criteria:
* \<18 years of age
* not living in the BDH catchment area
* not of African decent
* not willing to c…
Contacts